FATE
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Fate Therapeutics receives a CIRM CLIN2 grant to advance its RECLAIM-LN programSep 25, 2026
- Fate Therapeutics presented additional clinical data for its off-the-shelf CAR T-cell candidate FT819 at the CCR – West 2026 meetingSep 9, 2026
- Fate Therapeutics received FDA clearance for the IND application of FT839Jul 9, 2026
- Fate Therapeutics presents updated Phase 1 data for FT819 off-the-shelf CAR T-cell therapy in lupus erythematosusDec 8, 2025
- Fate Therapeutics to present Phase 1 data of FT819 CAR T-cell product for SLE at EULAR 2025 congressMay 29, 2025